{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:46:12Z","timestamp":1786995972912,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.prro.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:57:45Z","timestamp":1725695865000},"page":"e47-e56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-1130","authenticated-orcid":false,"given":"Sara. E.","family":"Beltran Ponce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Kamgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan R.","family":"Kharofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulwinder S.","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callisia N.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Aldakkak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.07.001_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: A review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2024.07.001_bib0002","series-title":"Cancer Facts and Figures 2023","year":"2023"},{"key":"10.1016\/j.prro.2024.07.001_bib0004","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.21037\/jgo-20-250","article-title":"Neoadjuvant treatment of localized pancreatic adenocarcinoma","volume":"12","author":"Leal","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0005","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.hoc.2022.07.004","article-title":"Novel considerations in surgical management of individuals with pancreatic adenocarcinoma","volume":"36","author":"Barnes","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.prro.2024.07.001_bib0006","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","article-title":"Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial","volume":"389","author":"Neoptolemos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2024.07.001_bib0007","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/bjs.4484","article-title":"Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma","volume":"91","author":"Wagner","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.prro.2024.07.001_bib0008","series-title":"Pancreatic adenocarcinoma (version 2.2022)","year":"2022"},{"key":"10.1016\/j.prro.2024.07.001_bib0009","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/ijms18081622","article-title":"Neoadjuvant therapy of pancreatic cancer: Definitions and benefits","volume":"18","author":"Heinrich","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.prro.2024.07.001_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13304-021-01186-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"74","author":"Gugenheim","year":"2022","journal-title":"Update Surg"},{"key":"10.1016\/j.prro.2024.07.001_bib0011","doi-asserted-by":"crossref","first-page":"E193","DOI":"10.2741\/A377","article-title":"Neoadjuvant chemoradiation for adenocarcinoma of the pancreas","volume":"3","author":"Breslin","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.prro.2024.07.001_bib0012","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/hpb.12400","article-title":"Trends in the use of pre-operative radiation for adenocarcinoma of the pancreas in the United States","volume":"17","author":"Burke","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.prro.2024.07.001_bib0013","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.hpb.2020.11.004","article-title":"Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer","volume":"23","author":"Zakem","year":"2021","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.prro.2024.07.001_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.2017-0208","article-title":"Predictors of response and survival in locally advanced adenocarcinoma of the pancreas following neoadjuvant GTX with or without radiation therapy","volume":"23","author":"Sherman","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.prro.2024.07.001_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/SLA.0000000000002705","article-title":"Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: A prospective, randomized, open-label, multicenter phase 2\/3 trial","volume":"268","author":"Jang","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2024.07.001_bib0016","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.21.01220","article-title":"Value of neoadjuvant radiation therapy in the management of pancreatic adenocarcinoma","volume":"39","author":"Hall","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0017","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: Long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0018","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ijrobp.2008.02.065","article-title":"Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: An analysis of data from the surveillance, epidemiology, and end results (SEER) registry","volume":"72","author":"Stessin","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.07.001_bib0019","doi-asserted-by":"crossref","first-page":"LBA4005","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA4005","article-title":"Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1)","volume":"41","author":"Labori","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0020","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1245\/s10434-020-09149-3","article-title":"Total neoadjuvant therapy for operable pancreatic cancer","volume":"28","author":"Kim","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0021","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/COC.0000000000000726","article-title":"Comparison of radiation treatment volumes for borderline resectable pancreatic cancer in contemporary clinical trials","volume":"43","author":"Bluemel","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.906484","article-title":"Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation","volume":"12","author":"Nelson","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0023","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/COC.0000000000000518","article-title":"Pattern of marginal local failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy for resectable and borderline resectable pancreas cancer","volume":"42","author":"Kharofa","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.21037\/hbsn.2019.11.26","article-title":"Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy","volume":"9","author":"Kim","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.prro.2024.07.001_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2018.10.008","article-title":"Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis","volume":"106","author":"Mackay","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2024.07.001_bib0026","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ijrobp.2013.09.005","article-title":"Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design","volume":"87","author":"Dholakia","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.07.001_bib0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-5-28","article-title":"Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: A pooled analysis of clinical evidence","volume":"5","author":"Sun","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0028","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319","article-title":"Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: The A021501 phase 2 randomized clinical trial","volume":"8","author":"Katz","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0029","doi-asserted-by":"crossref","first-page":"989","DOI":"10.21037\/jgo.2018.09.08","article-title":"Daily breathing inconsistency in pancreas SBRT: A 4DCT study","volume":"9","author":"Sarkar","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0030","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s13246-023-01324-6","article-title":"Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images","volume":"46","author":"Young","year":"2023","journal-title":"Phys Eng Sci Med"},{"key":"10.1016\/j.prro.2024.07.001_bib0031","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0000000000001602","article-title":"Patterns of failure after neoadjuvant stereotactic body radiation therapy or fractionated chemoradiation in resectable and borderline resectable pancreatic cancer","volume":"49","author":"Barrord","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.prro.2024.07.001_bib0032","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ejso.2010.07.003","article-title":"Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response","volume":"36","author":"Turrini","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0033","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jso.26313","article-title":"Controversies in radiotherapy for pancreas cancer","volume":"123","author":"Nehlsen","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.prro.2024.07.001_bib0034","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/0284186X.2018.1518593","article-title":"Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis","volume":"57","author":"van Erning","year":"2018","journal-title":"Acta Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T23:20:20Z","timestamp":1736292020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1879850024001577"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.07.001","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}